Collaboration – December 3, 2024
Capitainer plays a key role in the international AIR project (Artificial Intelligence Radiology) aimed at improving the diagnostics and monitoring of lung diseases.
Clinical Trials – December 3, 2024
The trial will be conducted in patients with pre-existing anti-AAV antibodies which limit use of gene therapy treatment.
Intellectual Property – December 2, 2024
The company has been granted a US patent for its SiPore platform technology.
Agreement – December 2, 2024
The two companies have decided to terminate the partnership agreement, covering the rights for Orexo to commercialize the digital mental health program for depression, Deprexis, in the US.
New Market – November 29, 2024
ScandiDos has announced that the prestigious Hospital Central de la Defensa Gómez Ulla (HCD Gómez Ulla) in Madrid has become a reference center for ScandiDos and the Delta4 family of products.
Clinical Trials – December 3, 2024
The trial will be conducted in patients with pre-existing anti-AAV antibodies which limit use of gene therapy treatment.
Clinical Trials – November 19, 2024
Modus Therapeutics has received approval from the relevant authorities in Italy for its planned Phase IIa clinical trial with sevuparin.
Clinical Trials – November 19, 2024
Alligator Bioscience and Aptevo Therapeutics report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, with more than half of evaluable patients achieved stable disease.
Clinical Trials – November 15, 2024
The company has presented positive Phase 2 data on its lead drug candidate mitazalimab in 1st line pancreatic cancer at the 39th Annual Meeting of the Society for Immunotherapy of Cancer, taking place November 6-10 in Houston, TX.
Clinical Trials – November 5, 2024
Medivir has announced a clinical trial collaboration and supply agreement with Eisai to evaluate fostrox in combination with lenvatinib mesylate in a randomized, phase 2b study in second-line advanced liver cancer patients.
Clinical Trials – October 29, 2024
Orexo has announced the first participants have been dosed with OX640, an intranasal rescue medication for severe allergic reactions (incl. anaphylaxis) with powder-based epinephrine, in a new study in subjects with allergic rhinitis (hay fever).
Biotech Business – November 20, 2024
Xbrane Biopharma and Intas Pharmaceuticals have announced an exclusive global licensing and co-development agreement for Xbrane´s Nivolumab Biosimilar candidate (referencing Opdivo).
Biotech Business – November 12, 2024
Kancera has announces the decision to focus its business on developing the company’s fractalkine blocking candidate drugs KAND567 and KAND145 to treat cardiovascular diseases, initially with focus on treatment of ST-elevation myocardial infarction (STEMI).
Financing – November 12, 2024
The company has announced a capital investment in the United States focused on expanding its research and manufacturing footprint by the end of 2026.
MedTech Business – November 13, 2024
Capitainer has announced the establishment of Capitainer Inc. in the United States. This expansion will enhance customer service and streamline order processing for the company’s growing US market, further strengthening Capitainer’s goal to become the gold standard and global leader in self-sampling, the company states.
Financing – November 12, 2024
The Board of Directors of SciBase has decided to carry out a capital raise totaling approximately SEK 81.8 million.
Financing – October 2, 2024
The Board of Directors of Spago Nanomedical has decided that the company’s resources will be focused on the development of Tumorad with the company’s primary priority being the execution of the ongoing clinical study Tumorad-01 with the candidate drug 177Lu-SN201.
Biotech Business – November 26, 2024
The rightsizing is expected to result in redundancy of approximately 20 percent of the employees across the CELLINK organization.
Biotech Business – November 25, 2024
During the World AMR Awareness Week (WAAW) NLS has chosen to highlight different Nordic companies and investors sharing what part of the solution they bring to the table and how their impact can be leveraged globally.
Biotech Business – November 25, 2024
BICO has entered into an agreement to divest Nanoscribe to LAB14 GmbH to an equity value of EUR 26 million.
Science – July 8, 2024
Unfortunately genes do matter when it comes to obesity, but knowledge about these genes and how they work are key to improving treatment and prevention.
Profiles in Science – June 18, 2024
Anna Falk, Head of Lund University’s Center for Advanced Therapies (LU-ATMP) and principal researcher of the Department of Neuroscience at Karolinska Institutet (KI) shares insights into her research, her multi-faceted job, and her vision for the future of neuroscience. Anna Falk is a molecular biologist with a PhD in neural stem cells and adult neurogenesis. […]
Science – September 20, 2023
An international team of scientists led by the University of Helsinki performed comprehensive mapping of structural alterations in cellular proteins during the aging process. In the study published in Molecular Cell, the team mapped structural alterations in cellular proteins during the aging process and, in the process, identifying new ways aging impacts how cells hum […]
MEQU
The Company °MEQU a Danish MedTech Start-up company placed in Copenhagen, manufactures the most effective portable blood and IV fluid warmer for use in emergency medical services and hospitals. °MEQU was founded in 2011 by Ulrik Krogh Andersen. The °M Warmer System was developed following a request from the Danish military to the Danish Technology […]
BÜCHI Labortechnik
The Company BÜCHI Labortechnik AG with headquarters in Flawil, Switzerland, is a leading provider of laboratory technology solutions for R&D, quality control and production worldwide. Established in 1939, BUCHI serves diverse industries such as pharmaceuticals, chemicals, food & beverage, feed, environmental analysis and academia. BÜCHI Labortechnik GmbH is a fully owned subsidiary of BÜCHI Labortechnik […]
Burner International
The Company Burner has been developing and manufacturing the original unbeatable Fire starters since 1992, when the company BURNER International A/S was founded in Denmark. Management and production remain in Denmark, ensuring the consistent delivery of high-quality products that comply with international ethical standards in retail trade (code of conduct). You will find the Burner […]
Avia Pharma
Take a key role in driving brand growth and expanding the Nordic market share within Women’s health.
Stryker
As a Sales Representative Endoscopy, you’ll help us deliver on our mission of making healthcare better by promoting and selling Stryker’s world-class Sports Medicine and Visualization products covering the Stockholm region.
Stryker
As Sales Representative, you will help us deliver on our mission of making healthcare better by promoting and selling Stryker’s Joint Replacement medical devices – in regions Sjælland & Hovedstaden.
In a new job – November 14, 2024
SmiLe Deputy CEO Ulrika Ringdahl takes over as new CEO of SmiLe.
In a new job – November 11, 2024
The Karolinska ATMP Centre is a joint venture between Karolinska Institutet and Karolinska University Hospital tasked with consolidating all ATMP operations based on cells, genes or tissues to enhance the development and implementation of cell, gene and tissue therapies.
In a new job – November 4, 2024
Åsa Uppströmer joins PharmaRelations from a position as branch manager for the Stockholm area in the large Frensch IT consulting group, Sogeti, part of the French listed giant Cap Gemini.
Careers article – November 7, 2024
Biotech talent in production is in high demand and Anocca is taking a creative approach to workforce development: investing in motivated young people through in-house training and education.
Careers article – October 14, 2024
Sweden boasts a global reputation for cutting-edge research and innovation, but the country’s ambition to maintain its leading position as an innovation nation faces a significant challenge: securing and retaining top talent from abroad. Why then is the route to work permits for international professionals complex and lengthy?
Careers article – October 11, 2024
Besides her technical knowledge in clinical development and clinical operations, leading and managing company and regulatory agencies’ teams has been a core aspect of Margrethe Sørgaard’s career path.
Profiles in Business – April 23, 2024
Despite being the co-founder of Ilya Pharma and co-director at the Science for Life Laboratory (SciLifeLab), Dr. Mia Phillipson, considers herself a scientist foremost, not an entrepreneur. “Most of all, I am a scientist. Yes, absolutely. This is my main occupation and the one in which I have the most expertise,” says Mia Phillipson, who […]
Business article – April 17, 2024
Personalized medicine, weight loss remedies and new treatments for widespread ailments are among the rising areas of high interest in the biotechnology and therapeutic arenas, according to executive chairman of Flerie Invest, Thomas Eldered. Thomas Eldered talked with Nordic Life Science about the Nordic and global life science financial landscapes and Flerie’s role in funding […]
Business – November 28, 2023
The previous founder and CEO of BioLamina has gone back to business development, and with his newly founded company he aims to redefine cell therapy development even further. Newly founded Alder Therapeutics is a preclinical phase stem cell therapy development company and, according to Kristian Tryggvason, co-founder and CEO, it is “the next big thing.” […]
This site uses cookies
